First received : February 9, 2011 .
Last updated : February 26, 2013 .
Last verified : February 2013 .
Phase I, Multicenter, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM060184 Administered Intravenously to Patients With Advanced Solid Tumors .
Recruitment Information
Status Recruiting
Start date 2011-01
Last follow-up date 2013-08 (Anticipated)
Primary completion date 2013-08 (Anticipated)
Organization name PharmaMar
Organization study ID PM60184-A-002-10
Sponsor PharmaMar
Health Authority United States: Food and Drug Administration